(Q40468021)

20 September 2017

title

QSAR and classification models of a novel series of COX-2 selective inhibitors: 1,5-diarylimidazoles based on support vector machines. (English)

1 reference

20 September 2017

main subject

support vector machine

1 reference

Liu HX

1

1 reference

20 September 2017

Zhang RS

2

1 reference

20 September 2017

Yao XJ

3

1 reference

20 September 2017

Liu MC

4

1 reference

20 September 2017

Hu ZD

5

1 reference

20 September 2017

Fan BT

6

1 reference

20 September 2017

publication date

1 June 2004

1 reference

Journal of Computer - Aided Molecular Design

20 September 2017

published in

1 reference

20 September 2017

volume

18

1 reference

20 September 2017

issue

6

1 reference

20 September 2017

page(s)

389-399

1 reference

Inhibition of cyclooxygenase: a novel approach to cancer prevention

20 September 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS10822-004-2722-1

The discovery of rofecoxib, [MK 966, Vioxx, 4-(4'-methylsulfonylphenyl)-3-phenyl-2(5H)-furanone], an orally active cyclooxygenase-2-inhibitor

21 January 2018

1 reference

12 December 2020

Prediction of protein structural classes by support vector machines.

1 reference

12 December 2020

Anti-inflammatory drugs: a hope for Alzheimer's disease?

1 reference

12 December 2020

Synthesis and biological evaluation of substituted 2-sulfonyl-phenyl-3-phenyl-indoles: a new series of selective COX-2 inhibitors

1 reference

12 December 2020

Gastrointestinal damage associated with the use of nonsteroidal antiinflammatory drugs

1 reference

12 December 2020

Prediction of the Effect of Mobile-Phase Salt Type on Protein Retention and Selectivity in Anion Exchange Systems

1 reference

12 December 2020

Human cyclooxygenase-2 cDNA

1 reference

12 December 2020

(E)-[2-(4-Methylsulphonylphenyl)-1-cyclopentenyl-1-methyliden](arylmethyloxy)amines. Methyleneaminoxymethyl (MAOM) analogues of diarylcyclopentenyl cyclooxygenase-2 inhibitors: synthesis and biological properties

1 reference

12 December 2020

Prostaglandins in peptic ulcer disease. An overview of current status and future directions

1 reference

12 December 2020

Amide derivatives of meclofenamic acid as selective cyclooxygenase-2 inhibitors

1 reference

12 December 2020

Diagnosing breast cancer based on support vector machines.

1 reference

12 December 2020

N-[[(5-methyl-3-phenylisoxazol-4-yl)-phenyl]sulfonyl]propanamide, sodium salt, parecoxib sodium: A potent and selective inhibitor of COX-2 for parenteral administration

1 reference

12 December 2020

Etoricoxib (MK-0663): preclinical profile and comparison with other agents that selectively inhibit cyclooxygenase-2.

1 reference

12 December 2020

Conformationally restricted 3,4-diarylfuranones (2,3a,4,5-tetrahydronaphthofuranones) as selective cyclooxygenase-2 inhibitors

1 reference

12 December 2020

Prediction of protein retention times in anion-exchange chromatography systems using support vector regression.

1 reference

12 December 2020

6-Alkyl, alkoxy, or alkylthio-substituted 3-(4-methanesulfonylphenyl)-4-phenylpyran-2-ones: a novel class of diarylheterocyclic selective cyclooxygenase-2 inhibitors

1 reference

12 December 2020

Synthesis and biological evaluation of the 1,5-diarylpyrazole class of cyclooxygenase-2 inhibitors: identification of 4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benze nesulfonamide (SC-58635, celecoxib).

1 reference

12 December 2020

COX-2 inhibitors vs. NSAIDs in gastrointestinal damage and prevention

1 reference

12 December 2020

Cyclooxygenase and inflammation in Alzheimer's disease: experimental approaches and clinical interventions

1 reference

12 December 2020

4-[5-Methyl-3-phenylisoxazol-4-yl]- benzenesulfonamide, valdecoxib: a potent and selective inhibitor of COX-2

1 reference

12 December 2020

Prediction of the isoelectric point of an amino acid based on GA-PLS and SVMs.

1 reference

12 December 2020

Mechanism of action of anti-inflammatory drugs.

1 reference

12 December 2020

Synthesis and structure-activity relationship of a new series of COX-2 selective inhibitors: 1,5-diarylimidazoles

1 reference

12 December 2020

Correlation of the solubilities of gases and vapors in methanol and ethanol with their molecular structures

1 reference

12 December 2020

Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing

1 reference

12 December 2020

Dexamethasone inhibits mitogen induction of the TIS10 prostaglandin synthase/cyclooxygenase gene

1 reference

12 December 2020

The cyclooxygenase-2 inhibitor celecoxib induces apoptosis by blocking Akt activation in human prostate cancer cells independently of Bcl-2

1 reference

12 December 2020

Topological indices: their nature and mutual relatedness

1 reference

12 December 2020

QSAR study of ethyl 2-[(3-methyl-2,5-dioxo(3-pyrrolinyl))amino]-4-(trifluoromethyl) pyrimidine-5-carboxylate: an inhibitor of AP-1 and NF-kappa B mediated gene expression based on support vector machines.

1 reference

12 December 2020

Identifying genes related to drug anticancer mechanisms using support vector machine

1 reference

12 December 2020

Drug design by machine learning: support vector machines for pharmaceutical data analysis

1 reference

12 December 2020

Renal syndromes associated with nonsteroidal antiinflammatory drugs

1 reference

12 December 2020

10.1007/S10822-004-2722-1

Identifiers

DOI

1 reference

journals/jcamd/LiuZYLHF04

20 September 2017

DBLP publication ID

1 reference

DBLP Dataset 2021-01-02

Dimensions Publication ID

28 January 2021

1034716605

0 references

1 reference